We are monitoring the impact of COVID-19 on APAC Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1128
Share on
Share on

Asia Pacific Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1128
Pages: 134

APAC Autoimmune Diagnostics Market Size (2021 to 2026)

The size of the Asia-Pacific autoimmune diagnostics market is forecasted to be growing at a CAGR of 4% from 2021 to 2026. The market size is estimated to be worth USD 2.83 billion by 2026 and USD 2.33 billion in 2021.

The APAC autoimmune diagnostics market is primarily driven by a few key factors such as the rising prevalence of autoimmune disease, patient awareness of rising healthcare concerns, increased healthcare expenditure, rising government initiatives, and increased automation technologies leading to higher sensitivity, faster and easier diagnosis test results, and prevention of disease. Various multinational companies are setting up operations in this region, intending to gain a large revenue share from emerging countries, raise healthcare concerns, and improving the region's healthcare scenario are the factors that will fuel the growth of Autoimmune Diagnostics Market in Asia-Pacific. Autoimmune Disease is a type of autoimmune disease. The growing incidence of diseases including rheumatoid arthritis and Hashimoto's thyroiditis and favorable government regulations would have a substantial influence on the growth of the Asia Pacific Autoimmune diagnostics market.

Rapid technical advances in the medical area, such as innovative biomarkers, rising healthcare expenditures, developing market development, and favorable government initiatives, are projected to provide lucrative opportunities for market expansion. As the use of Electronic Medical Records (EMR) grows, labs will have access to real-time test data and metrics extracted from the Laboratory Information System (LIS), and physicians will have access to these records as well, increasing diagnosis efficiency and boosting the autoimmune diagnostics market in this region. The growing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations to raise awareness about autoimmune diseases, discovering biomarkers, and surging strategic developments among major players are all driving the market forward.

The high expense of therapy, the lack of an absolute cure, and the risky nature of biologics are expected to restrain the APAC autoimmune diagnostics market growth. The investment of a diagnosis center necessitates a large sum of money, which will be a stumbling block to the market's expansion in this region, where people cannot afford diagnostic services.

The Asia Pacific Autoimmune Diagnostics Market faces many challenges, including a high rate of false-positive results and a long turnaround time for diagnostic test results. Due to a lack of information about various diseases and diagnostic procedures, the Autoimmune Disease Diagnostics Market faces significant challenges.

This research report is on the Asia Pacific Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:

By Test Type:

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel  
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)     
  • Others

By Disease Type:

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

By End User:

  • Hospitals
  • Research Centres
  • Diagnostic Laboratories

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Due to increased disposable income and an expanding patient pool in emerging nations, Asia-Pacific is expected to see significant market development over the forecast period. The Asia-Pacific area has improved its healthcare situation by introducing novel diagnostic products, which are expected to enhance these diagnostic tests across the continent, making it the fastest expanding region in the Autoimmune Diagnostics Market. The majority of producers in the Asia-Pacific area have concentrated on producing generic versions of biological medicines, which are frequently utilized as first-line treatments. The autoimmune disease diagnostics market in the Asia-Pacific region is expected to grow due to rising awareness of the benefits of early and accurate diagnosis of autoimmune diseases to seek proper care, rising healthcare infrastructure development, and rising healthcare expenditure.

KEY MARKET PLAYERS:

A few of the notable companies in the APAC Autoimmune disease market profiled in this report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Autoimmune diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Autoantibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Antinuclear Antibody Tests Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Complete Blood Count (CBC) Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific C - reactive protein (CRP) Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Comprehensive Metabolic panel Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Urinalysis Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Other Test Types Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Localized Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  14. China Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  15. China Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  16. India Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  17. India Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  18. Japan Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  19. Japan Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  20. South Korea Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  21. South Korea Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  22. Australia Autoimmune diagnostics Market, By Test Type, From 2021 to 2026 (USD Million)
  23. Australia Autoimmune diagnostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  24. Asia-Pacific Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  25. Asia-Pacific Graves' Disease Market, By Region, From 2021 to 2026 (USD Million)
  26. Asia-Pacific Hashimoto's Thyroiditis Market, By Region, From 2021 to 2026 (USD Million)
  27. Asia-Pacific Multiple Sclerosis Market, By Region, From 2021 to 2026 (USD Million)
  28. Asia-Pacific Type 1 diabetes Market, By Region, From 2021 to 2026 (USD Million)
  29. Asia-Pacific Psoriasis Market, By Region, From 2021 to 2026 (USD Million)
  30. Asia-Pacific Other Localized Autoimmune Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  31. China Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  32. India Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  33. Japan Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  34. South Korea Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  35. Australia Localized Autoimmune Disease Diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  36. Asia-Pacific Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  37. Asia-Pacific Rheumatoid Arthritis (RA) Market, By Region, From 2021 to 2026 (USD Million)
  38. Asia-Pacific Ankylosing Spondylitis Market, By Region, From 2021 to 2026 (USD Million)
  39. Asia-Pacific Systemic Lupus Erythematosus (SLE) Market, By Region, From 2021 to 2026 (USD Million)
  40. China Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  41. India Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  42. Japan Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  43. South Korea Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)
  44. Australia Systemic Auto-immune disease diagnostics Market, By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample